PharmacoGenetics (China)

950 papers and 23.9k indexed citations i.

About

In recent decades, authors affiliated with PharmacoGenetics (China) have published 950 papers, which have received a total of 23.9k indexed citations. Scholars at this organization have produced 397 papers in Molecular Biology, 221 papers in Pharmacology and 196 papers in Oncology on the topics of Pharmacogenetics and Drug Metabolism (196 papers), Drug Transport and Resistance Mechanisms (112 papers) and Cancer-related molecular mechanisms research (54 papers). Their work is cited by papers focused on Molecular Biology (9.9k citations), Oncology (4.8k citations) and Pharmacology (4.8k citations). Authors at PharmacoGenetics (China) collaborate with scholars in Hong Kong, China and United States and have published in prestigious journals including Proceedings of the National Academy of Sciences, Angewandte Chemie International Edition and Journal of Biological Chemistry. Some of PharmacoGenetics (China)'s most productive authors include Zhaoqian Liu, Hong‐Hao Zhou, Ji‐Ye Yin, Wei Zhang, Hong‐Hao Zhou, Howard L. McLeod, Hong‐Hao Zhou, Daniel Morgensztern, Zhi‐Rong Tan and Gerald W. Dorn.

In The Last Decade

Fields of papers published by authors at PharmacoGenetics (China)

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers affiliated with PharmacoGenetics (China) at the time of their publication. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers affiliated with PharmacoGenetics (China) at the time of their publication.

Countries citing scholars working at PharmacoGenetics (China)

Since Specialization
Citations

This map shows the geographic impact of research produced by authors working at PharmacoGenetics (China). It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by papers produced at PharmacoGenetics (China) with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites PharmacoGenetics (China) more than expected).

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar’s output or impact.

Explore institutions with similar magnitude of impact

Rankless by CCL
2025